packageRisankizumab

risankizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Risankizumab is a monoclonal antibody used to treat psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. It is an approved interleukin inhibitor and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q25112466 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:risankizumab
ATC codes:L04AC18
DrugBank:DB14762
Wikidata:Q25112466
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown